尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Browse the full record of transactions filed by Arsenault Kaitlyn Melanie, 首席财务官. Director active across 1 company, notably Skye Bioscience, Inc.. In total, 1 reports have been published. Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Kaitlyn Melanie Arsenault serves as Chief Financial Officer at Skye Bioscience, Inc. In this role, she oversees the company's financial operations, ensuring compliance and efficiency in accounting processes. Arsenault plays a key role in financial planning and the company's growth strategy. Her financial expertise is essential for the success of Skye Bioscience.